Published in:
Open Access
01-05-2019 | Embryo Biology
Compromised global embryonic transcriptome associated with advanced maternal age
Authors:
Blair R. McCallie, Jason C. Parks, G. Devon Trahan, Kenneth L. Jones, Breanne D. Coate, Darren K. Griffin, William B. Schoolcraft, Mandy G. Katz-Jaffe
Published in:
Journal of Assisted Reproduction and Genetics
|
Issue 5/2019
Login to get access
Abstract
Purpose
To investigate the global transcriptome and associated embryonic molecular networks impacted with advanced maternal age (AMA).
Methods
Blastocysts derived from donor oocyte IVF cycles with no male factor infertility (< 30 years of age) and AMA blastocysts (≥ 42 years) with no other significant female factor infertility or male factor infertility were collected with informed patient consent. RNA sequencing libraries were prepared using the SMARTer® Ultra® Low Kit (Clontech Laboratories) and sequenced on the Illumina HiSEQ 4000. Bioinformatics included Ingenuity® Pathway Analysis (Qiagen) with ViiA™ 7 qPCR utilized for gene expression validation (Applied Biosystems).
Results
A total of 2688 significant differentially expressed transcripts were identified to distinguish the AMA blastocysts from young, donor controls. 2551 (95%) of these displayed decreased transcription in the blastocysts from older women. Pathway analysis revealed three altered molecular signaling networks known to be critical for embryo and fetal development: CREBBP, ESR1, and SP1. Validation of genes within these networks confirmed the global decreased transcription observed in AMA blastocysts (P < 0.05).
Conclusions
A significant, overall decreased global transcriptome was observed in blastocysts from AMA women. The ESR1/SP1/CREBBP pathway, in particular, was found to be a highly significant upstream regulator impacting biological processes that are vital during embryonic patterning and pre-implantation development. These results provide evidence that AMA embryos are compromised on a cell signaling level which can repress the embryo’s ability to proliferate and implant, contributing to a deterioration of reproductive outcomes.